MARKSANS PHARMA. share price has zoomed 6% and is presently trading at Rs 199.3.
Meanwhile, the BSE HEALTHCARE index is at 39,061.4 (up 0.8%).
Among the top gainers in the BSE HEALTHCARE index today are ALEMBIC PHARMA (up 8.8%) and HIKAL CHEMIC (up 3.2%).
Torrent Pharma (down 2.9%) and ASTRAZENECA PHARMA (down 2.2%) are among the top losers today.
Over the last one year, MARKSANS PHARMA. has moved up from Rs 105.5 to Rs 199.3, registering a gain of Rs 93.8 (up 88.9%).
On the other hand, the BSE HEALTHCARE index has moved up from 26,789.0 to 39,061.4, registering a gain of 45.8% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were GSK Pharma (up 95.9%), Lupin (up 94.1%) and Jubilant Pharmova (up 94.1%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 80,000.7 (down 0.5%).
The top losers among the BSE Sensex today are Bajaj Finance (down 2.2%) and Axis Bank (down 2.1%). The most traded stocks in the BSE Sensex are Tata Steel and ITC.
In the meantime, NSE Nifty is at 24,379.9 (down 0.4%). Axis Bank and Bajaj Finance are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,384.8 to 80,000.7, registering a gain of 13,615.9 points (up 20.5%).
MARKSANS PHARMA. net profit fell 6.1% YoY to Rs 776 million for the quarter ended March 2024, compared to a profit of Rs 827 million a year ago. Net sales rose 15.2% to Rs 5,600 million during the period as against Rs 4,860 million in January-March 2023.
For the year ended March 2023, MARKSANS PHARMA. reported 42.0% increase in net profit to Rs 2,653 million compared to net profit of Rs 1,868 million during FY22. Revenue of the company grew 24.2% to Rs 18,521 million during FY23.
The current Price to earnings ratio of MARKSANS PHARMA., based on rolling 12 month earnings, stands at 28.7.
Equitymaster requests your view! Post a comment on "MARKSANS PHARMA. Gains 6%; BSE HEALTHCARE Index Up 0.8%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!